503 related articles for article (PubMed ID: 29105277)
1. Effect of human amniotic epithelial cells on pro-fibrogenic resident hepatic cells in a rat model of liver fibrosis.
Cargnoni A; Farigu S; Cotti Piccinelli E; Bonassi Signoroni P; Romele P; Vanosi G; Toschi I; Cesari V; Barros Sant'Anna L; Magatti M; Silini AR; Parolini O
J Cell Mol Med; 2018 Feb; 22(2):1202-1213. PubMed ID: 29105277
[TBL] [Abstract][Full Text] [Related]
2. Soluble factors derived from human amniotic epithelial cells suppress collagen production in human hepatic stellate cells.
Hodge A; Lourensz D; Vaghjiani V; Nguyen H; Tchongue J; Wang B; Murthi P; Sievert W; Manuelpillai U
Cytotherapy; 2014 Aug; 16(8):1132-44. PubMed ID: 24642017
[TBL] [Abstract][Full Text] [Related]
3. Transplantation of human amnion epithelial cells reduces hepatic fibrosis in immunocompetent CCl₄-treated mice.
Manuelpillai U; Tchongue J; Lourensz D; Vaghjiani V; Samuel CS; Liu A; Williams ED; Sievert W
Cell Transplant; 2010; 19(9):1157-68. PubMed ID: 20447339
[TBL] [Abstract][Full Text] [Related]
4. The characteristics of activated portal fibroblasts/myofibroblasts in liver fibrosis.
Karin D; Koyama Y; Brenner D; Kisseleva T
Differentiation; 2016 Sep; 92(3):84-92. PubMed ID: 27591095
[TBL] [Abstract][Full Text] [Related]
5. Role of TGF-β signaling in differentiation of mesothelial cells to vitamin A-poor hepatic stellate cells in liver fibrosis.
Li Y; Lua I; French SW; Asahina K
Am J Physiol Gastrointest Liver Physiol; 2016 Feb; 310(4):G262-72. PubMed ID: 26702136
[TBL] [Abstract][Full Text] [Related]
6. Human amniotic epithelial cell transplantation induces markers of alternative macrophage activation and reduces established hepatic fibrosis.
Manuelpillai U; Lourensz D; Vaghjiani V; Tchongue J; Lacey D; Tee JY; Murthi P; Chan J; Hodge A; Sievert W
PLoS One; 2012; 7(6):e38631. PubMed ID: 22719909
[TBL] [Abstract][Full Text] [Related]
7. Human amnion epithelial cells and their soluble factors reduce liver fibrosis in murine non-alcoholic steatohepatitis.
Kuk N; Hodge A; Sun Y; Correia J; Alhomrani M; Samuel C; Moore G; Lim R; Sievert W
J Gastroenterol Hepatol; 2019 Aug; 34(8):1441-1449. PubMed ID: 30821873
[TBL] [Abstract][Full Text] [Related]
8. Cellular sources of extracellular matrix in hepatic fibrosis.
Wells RG
Clin Liver Dis; 2008 Nov; 12(4):759-68, viii. PubMed ID: 18984465
[TBL] [Abstract][Full Text] [Related]
9. Fibronectin extra domain-A promotes hepatic stellate cell motility but not differentiation into myofibroblasts.
Olsen AL; Sackey BK; Marcinkiewicz C; Boettiger D; Wells RG
Gastroenterology; 2012 Apr; 142(4):928-937.e3. PubMed ID: 22202457
[TBL] [Abstract][Full Text] [Related]
10. Specific activation of the different fibrogenic cells in rat cultured liver slices mimicking in vivo situations.
Guyot C; Combe C; Clouzeau-Girard H; Moronvalle-Halley V; Desmoulière A
Virchows Arch; 2007 May; 450(5):503-12. PubMed ID: 17431675
[TBL] [Abstract][Full Text] [Related]
11. H19/miR-148a/USP4 axis facilitates liver fibrosis by enhancing TGF-β signaling in both hepatic stellate cells and hepatocytes.
Zhu J; Luo Z; Pan Y; Zheng W; Li W; Zhang Z; Xiong P; Xu D; Du M; Wang B; Yu J; Zhang J; Liu J
J Cell Physiol; 2019 Jun; 234(6):9698-9710. PubMed ID: 30362572
[TBL] [Abstract][Full Text] [Related]
12. Anti-fibrotic effects of fresh and cryopreserved human amniotic membrane in a rat liver fibrosis model.
Ricci E; Vanosi G; Lindenmair A; Hennerbichler S; Peterbauer-Scherb A; Wolbank S; Cargnoni A; Signoroni PB; Campagnol M; Gabriel C; Redl H; Parolini O
Cell Tissue Bank; 2013 Sep; 14(3):475-88. PubMed ID: 22926336
[TBL] [Abstract][Full Text] [Related]
13. Osteopontin induces ductular reaction contributing to liver fibrosis.
Wang X; Lopategi A; Ge X; Lu Y; Kitamura N; Urtasun R; Leung TM; Fiel MI; Nieto N
Gut; 2014 Nov; 63(11):1805-18. PubMed ID: 24496779
[TBL] [Abstract][Full Text] [Related]
14. Hepatic myofibroblasts: a heterogeneous population of multifunctional cells in liver fibrogenesis.
Novo E; di Bonzo LV; Cannito S; Colombatto S; Parola M
Int J Biochem Cell Biol; 2009 Nov; 41(11):2089-93. PubMed ID: 19782946
[TBL] [Abstract][Full Text] [Related]
15. Rapamycin inhibits hepatic fibrosis in rats by attenuating multiple profibrogenic pathways.
Bridle KR; Popa C; Morgan ML; Sobbe AL; Clouston AD; Fletcher LM; Crawford DH
Liver Transpl; 2009 Oct; 15(10):1315-24. PubMed ID: 19790156
[TBL] [Abstract][Full Text] [Related]
16. Role of NADPH oxidases in the redox biology of liver fibrosis.
Crosas-Molist E; Fabregat I
Redox Biol; 2015 Dec; 6():106-111. PubMed ID: 26204504
[TBL] [Abstract][Full Text] [Related]
17. Amniotic membrane application reduces liver fibrosis in a bile duct ligation rat model.
Sant'Anna LB; Cargnoni A; Ressel L; Vanosi G; Parolini O
Cell Transplant; 2011; 20(3):441-53. PubMed ID: 20719087
[TBL] [Abstract][Full Text] [Related]
18. Study on the relationship between hepatic fibrosis and epithelial-mesenchymal transition in intrahepatic cells.
Chen Y; Fan Y; Guo DY; Xu B; Shi XY; Li JT; Duan LF
Biomed Pharmacother; 2020 Sep; 129():110413. PubMed ID: 32570119
[TBL] [Abstract][Full Text] [Related]
19. FXR agonist obeticholic acid reduces hepatic inflammation and fibrosis in a rat model of toxic cirrhosis.
Verbeke L; Mannaerts I; Schierwagen R; Govaere O; Klein S; Vander Elst I; Windmolders P; Farre R; Wenes M; Mazzone M; Nevens F; van Grunsven LA; Trebicka J; Laleman W
Sci Rep; 2016 Sep; 6():33453. PubMed ID: 27634375
[TBL] [Abstract][Full Text] [Related]
20. Human induced pluripotent stem cell-derived extracellular vesicles reduce hepatic stellate cell activation and liver fibrosis.
Povero D; Pinatel EM; Leszczynska A; Goyal NP; Nishio T; Kim J; Kneiber D; de Araujo Horcel L; Eguchi A; Ordonez PM; Kisseleva T; Feldstein AE
JCI Insight; 2019 Jun; 5(14):. PubMed ID: 31184999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
